Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

The global weight-loss drug market, once dominated by Novo Nordisk, is undergoing a dramatic transformation. On Friday, the ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

A Boston-based biopharmaceutical company is revolutionizing the weight-loss drug industry. Syntis Bio has created a daily ...

Pfizer's anti-GDF-15 antibody ponsegromab was able to achieve weight gain ... programme for the drug next year. Cachexia is a complicated metabolic disorder that results in loss of muscle and ...

It is the first criminal drug distribution prosecution related to telemedicine prescribing through a digital health company, according to the DoJ. The Centers for Disease Control and Prevention ...